Channel
GeneDx Q1 Revenues Soar 42 Percent Driven by Genome, Exome Testing Demand
The company updated its full-year 2025 guidance to include $3 million to $5 million in additional revenue following the planned Fabric Genomics acquisition.
The company said that its test could overcome sensitivity issues with ultrasound and serum alpha-fetoprotein assays that are used to monitor at-risk patients.
Qiagen highlighted new products for biopharma, next-generation sequencing, and sample prep at AACR this week.
Acute Myeloid Leukemia Differentiation States Characterized With Single-Cell Reference Atlas
Researchers mapped single-cell gene expression in healthy hematopoietic cells, using this atlas to find AML differentiation patterns and related driver genes.
Newly Formed Advocacy Group Urges FDA Action on Alzheimer's Disease Risk Gene
The ApoE4 Alzheimer's Alliance is calling for an increased focus on patients with ApoE4, a gene variant associated with increased Alzheimer's risk.